Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-19-041988

SVP & Chief Financial Officer sold 25,000 shares at $34.57 ($864,250)

  • SVP & Chief Financial Officer acquired 25,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Labrucherie Gil M · SVP & Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2019-07-10 Exercise or conversion : show line 1 in the form +25,000 $7.21 $180,250 152,935 D
2019-07-10 Sale : show line 2 in the form −25,000 $34.57 $864,250 127,935 D
Open-market sales · 25,000 sh · avg $34.57 · $864,250

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-07-10 Exercise or conversion : show line 3 in the form Stock Option −25,000 25,000 D
Loading xslF345X03/doc4.xml…